ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,870Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 6969

$937K Total Retail Price of All Prescriptions

Rank: 152 out of 6969

555 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 555 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

15% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 12,603 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 698 557 1 4
LEVOTHYROXINE SODIUM 590 466 2 5
WARFARIN SODIUM 413 346 3 20
BENAZEPRIL HCL 386 276 4 18
FUROSEMIDE 386 326 4 10
OMEPRAZOLE 374 273 6 6
SIMVASTATIN 359 282 7 1
NAMENDA 329 324 8 51
HYDROCODONE-ACETAMINOPHEN 319 257 S3 9 3
ALENDRONATE SODIUM 299 273 10 14
DONEPEZIL HCL 280 261 11 32
DIVALPROEX SODIUM 238 167 12 103
GABAPENTIN 237 187 13 17
POTASSIUM CHLORIDE 236 187 14 30
LISINOPRIL 233 207 15 2
CARVEDILOL 194 158 16 25
METOPROLOL TARTRATE 181 160 17 13
PRAVASTATIN SODIUM 177 114 18 19
METFORMIN HCL 173 132 19 7
LANTUS 172 127 20 50
GLIPIZIDE 169 141 21 21
HYDROCHLOROTHIAZIDE 168 121 22 8
ZOLPIDEM TARTRATE 151 130 23 16
GEMFIBROZIL 149 95 24 85
ATENOLOL 143 120 25 9
EXELON 140 140 26 157
FAMOTIDINE 140 124 26 37
ATORVASTATIN CALCIUM 139 101 28 11
LOSARTAN POTASSIUM 130 112 29 12
TRAMADOL HCL 128 103 30 27
PANTOPRAZOLE SODIUM 126 102 31 31
TAMSULOSIN HCL 111 99 32 23
AMLODIPINE BESYLATE-BENAZEPRIL 109 80 33 91
ALBUTEROL SULFATE 106 66 34 123
PROAIR HFA 102 58 35 33
MIRTAZAPINE 102 101 35 76
JANUVIA 101 101 37 41
ALLOPURINOL 100 88 38 35
TRIAMCINOLONE ACETONIDE 100 77 38 55
DIGOXIN 100 91 38 71
LEVETIRACETAM 95 41 41 128
RISPERIDONE 94 94 42 88
PAROXETINE HCL 93 86 43 65
HUMULIN R 92 82 44 223
ENALAPRIL MALEATE 91 78 45 56
AMIODARONE HCL 90 81 46 184
TRAZODONE HCL 84 84 47 47
FLUTICASONE PROPIONATE 83 69 48 24
PHENYTOIN SODIUM EXTENDED 82 45 49 169
LACTULOSE 80 60 50 131
LABETALOL HCL 78 72 51 300
LEVOFLOXACIN 78 66 51 109
IPRATROPIUM BROMIDE 77 41 53 179
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 60 53 114
QUETIAPINE FUMARATE 74 72 55 101
CARBIDOPA-LEVODOPA 74 58 55 119
NOVOLIN R 73 62 57 161
METOPROLOL SUCCINATE 71 63 58 22
TERAZOSIN HCL 71 47 58 49
SPIRIVA 70 70 60 66
ADVAIR DISKUS 69 45 61 45
PREDNISONE 69 63 61 70
CLONIDINE HCL 67 36 63 59
MEGESTROL ACETATE 67 67 R 63 129
DIOVAN 66 61 65 26
AZITHROMYCIN 63 49 66 42
SEROQUEL 62 61 67 205
CIPROFLOXACIN HCL 61 52 68 64
CYMBALTA 60 44 69 72
POLYETHYLENE GLYCOL 3350 60 51 69 127
ABILIFY 60 30 69 173
GALANTAMINE HBR 59 59 72 275
ISOSORBIDE DINITRATE 58 50 73 231
METOCLOPRAMIDE HCL 57 52 74 136
SINGULAIR 56 47 75 84
OLANZAPINE 56 47 75 139
FENTANYL 55 54 S2 77 113
SERTRALINE HCL 54 34 78 38
AVODART 52 50 79 108
LORAZEPAM 51 48 80 186
NYSTATIN 50 33 81 215
HYDROXYZINE HCL 50 37 R 81 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.